sulfatinib

Small moleculeexperimental

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • hmpl-012
  • sufatinib
  • sulfatinib
  • sulfatinib
  • sulfatinib

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06884345Phase 1/Phase 2 (Phase 2)Mar 13, 2025Anhui Medical University
NCT05697237N/AJan 31, 2023Jiao Tong University
NCT05590572Phase 1/Phase 2 (Phase 2)Jan 31, 2023Chonnam National University, Jiao Tong University, Peking University, Shandong University, Zhejiang University
NCT03627520Early Phase 1 (Phase 1)Apr 2, 2018Hutchison MediPharma
NCT03483259Phase 1Apr 2, 2018Hutchison MediPharma, Shanghai Xuhui District Central Hospital
NCT02966821Phase 2Dec 1, 2016Hutchison MediPharma, People's Liberation Army of China
NCT02614495Phase 2Feb 1, 2016Hutchison MediPharma
NCT02589821Phase 3Dec 7, 2015Hutchison MediPharma
NCT02588170Phase 3Dec 7, 2015Hutchison MediPharma
NCT02549937Phase 1Nov 1, 2015Hutchison MediPharma
NCT02320409Phase 1Dec 1, 2014Hutchison MediPharma, Shanghai Xuhui District Central Hospital
NCT02267967Phase 1Oct 31, 2014Hutchison MediPharma
NCT02133157Phase 1Apr 1, 2010Hutchison MediPharma, People's Liberation Army of China
Showing 13 of 13 trials
Page 1 / 1

Organizations

Research & Development (9)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Hutchison MediPharmaFor profit101032010
Jiao Tong UniversityAcademic/Hospital2122023
People's Liberation Army of ChinaGovernment2022010
Shanghai Xuhui District Central HospitalAcademic/Hospital2012014
Anhui Medical UniversityAcademic/Hospital1112025
Chonnam National UniversityAcademic/Hospital1012023
Peking UniversityAcademic/Hospital1012023
Shandong UniversityAcademic/Hospital1012023
Zhejiang UniversityAcademic/Hospital1112023
9 organizations
Page 1 / 1